Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

AG Mortgage Investment Trust Inc MITT

Alternate Symbol(s):  MITT.P.A | MITT.P.B

AG Mortgage Investment Trust, Inc. is a residential mortgage real estate investment trust (REIT). The Company is focused on investing in a diversified, risk-adjusted portfolio of residential mortgage-related assets in the United States mortgage market. The Company's objective is to provide attractive risk-adjusted returns to its stockholders over the long-term, primarily through dividends and capital appreciation. The Company's investment portfolio includes Residential Investments and Agency residential mortgage-backed securities (RMBS). Its residential investments primarily consist of newly originated Non-Agency Loans and Agency-Eligible Loans. In addition to its Residential Investments, the Company also invests in other types of residential mortgage loans and other mortgage related assets. Its investment portfolio also includes Re/Non-Performing Loans, Land Related Financing and Agency RMBS. Agency RMBS represent interests in pools of residential mortgage loans guaranteed by a GSE.


NYSE:MITT - Post by User

Post by LeaMileson Apr 16, 2022 11:30am
104 Views
Post# 34607490

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>